Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments
Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments
Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments
Submitted by
admin
on December 3, 2011 - 3:50pm
Source:
Forbes
News Tags:
Spectrum Pharmaceuticals
Zevalin
non-Hodgkin's lymphoma
osteosarcoma
Fusilev
Headline:
Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments
Do Not Allow Advertisers to Use My Personal information